Report Categories
View AllRecent Articles
View All
PFGC Performance reports Q1 2026 EPS miss of 119 percent shares trade nearly flat on muted investor reaction
Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings
KCHV Kochav cites defense sector acquisition opportunities as top strategic priority in latest quarterly earnings update